Perfusion Medical LLC
Perfusion Medical is dedicated to commercializing PEG-20k, a revolutionary drug designed to treat hemorrhagic shock and other ischemic conditions. With over $18 million in funding from the Department of Defense and numerous studies supporting its efficacy, the company aims to improve patient outcomes significantly.
Industries
N/A
Nr. of Employees
small (1-50)
Perfusion Medical LLC
12110 Sunset Hills Rd Suite 600, Reston, VA 20190, USA; 800 East Leigh Street, Richmond, VA 23219, USA
Products
Investigational high-molecular-weight polyethylene glycol intravenous resuscitation solution (investigational)
An investigational intravenous solution formulated with high-molecular-weight polyethylene glycol intended to reduce ischemic tissue swelling, decompress capillaries, restore microcirculatory perfusion, and improve oxygen delivery in hemorrhagic shock and other ischemic conditions.
Investigational high-molecular-weight polyethylene glycol intravenous resuscitation solution (investigational)
An investigational intravenous solution formulated with high-molecular-weight polyethylene glycol intended to reduce ischemic tissue swelling, decompress capillaries, restore microcirculatory perfusion, and improve oxygen delivery in hemorrhagic shock and other ischemic conditions.
Services
Coordination and management of contract research organizations and external vendors for preclinical testing, regulatory support, and legal/IP services.
Program-level management of preclinical-to-commercial development activities, funding coordination, and commercialization planning.
Coordination and management of contract research organizations and external vendors for preclinical testing, regulatory support, and legal/IP services.
Program-level management of preclinical-to-commercial development activities, funding coordination, and commercialization planning.
Expertise Areas
- Trauma resuscitation therapeutics
- Preclinical large-animal efficacy studies
- Intravenous formulation and CMC development
- Regulatory strategy for investigational IV therapeutics
Key Technologies
- High-molecular-weight polyethylene glycol IV formulations
- Large-animal hemorrhagic shock models (swine, rodent)
- Osmotic-gradient-based tissue decompression mechanism
- Physiological monitoring of perfusion and coronary perfusion pressure